Mechanistically, enhanced serotonin transmission can lower the epileptic threshold by concurrently activating 5-HT1A and 5-HT2 receptors in the brainstem, potentially triggering myoclonus or epileptic seizures. The gene discussed is HTR2A; the disease is Seizure.